Viral Genetics Creates Subsidiary to Develop Cancer Therapy
SAN MARINO, Calif., Aug. 7 /PRNewswire-FirstCall/ -- Biotechnology company Viral Genetics (Pink Sheets: VRAL) has formed a wholly owned subsidiary called MetaCytoLytics, Inc. This company was created to advance a technology developed by University of Colorado Professor M. Karen Newe...
Patton Medical Devices Partners With Unomedical to Develop and Market the i-port Advance(TM) Injection Port for People Taking Multiple Daily Injections
AUSTIN, Texas, July 27 /PRNewswire/ -- Patton Medical Devices, manufacturer of the i-port(R) and a leader of injection port therapy, announced today that they have entered into a partnership agreement with Unomedical, a leading manufacturer of single use medical devices used in th...
DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies
DNA Software, Inc. has been awarded three Fast Track SBIR grants from the National Institutes of Health to develop
original in silico technologies to predict 3D structures of RNA-based molecules, improve diagnostics via modified nucleotides, and model the reaction rates of DNA and RNA experiments...
Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders
SALT LAKE CITY, July 22 /PRNewswire/ -- Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, and the University of Utah today announced that they have entered into a collaboration that allows Axial access to the University's rich ...
iSource Networks Partners with inVentiv Health to Develop New Technology Platform for Reaching Healthcare Consumers
NEWPORT, R.I., July 20 /PRNewswire/ -- iSource Networks, a company focused on improving patient-driven self-care, announced today that it will partner with inVentiv Health, the leading provider of commercialization solutions to the healthcare industry, to develop
an innovative new techno...
Synthetic Genomics Inc. and ExxonMobil Research and Engineering Company Sign Exclusive, Multi-Year Agreement to Develop Next Generation Biofuels Using Photosynthetic Algae
LA JOLLA, Calif., July 14 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company applying genomic-driven commercial solutions to address a variety of global challenges including energy and the environment, announced today a multi-year research and development agreement with E...
DuPont and Arzeda Collaborate to Develop Improved Crops to Increase Productivity
Custom Enzyme Design Technology to Bring More Options to Global Agriculture
Des Moines, Iowa and Seattle, Wash. (Vocus) July 13, 2009 -- DuPont and Arzeda Corp. today announced a technology collaboration to develop
new traits to increase agricultural productivity. ...
The Leukemia & Lymphoma Society and The International Waldenstrom's Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research
WHITE PLAINS, N.Y., July 6 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and The International Waldenstrom's Macroglobulinemia Foundation (IWMF) have partnered in an initiative to develop
stable and immortalized Waldenstrom's macroglobulinemia (WM) cell lines that would be made widely ...
Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
EXTON, Penn., July 1 /PRNewswire/ -- Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced a research collaboration agreement with Synageva BioPharma Corporation to express and develop
therapeutic monoclonal antibodies for the potential treatment of various forms of can...
Kornberg Associates Architects Selected to Develop Design for New Stanford University Imaging Center
MENLO PARK, Calif., June 29 /PRNewswire/ -- Kornberg Associates | Architects ( www.kornberg.com ) has been selected by Stanford University to design a new Cognitive & Neurobiological Imaging Center. Ken Kornberg, president and founder, made the announcement. The firm has worked with Sta...
Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)
Partnership will offer expanded access to choice, quality and cost-efficiency for patients and payers
WICHITA, Kan. and AVENTURA, Fla., June 24 /PRNewswire/ -- Galichia Heart Hospital and Mobile Surgery International (MSI) have reached an agreement for Galichia to host MSI-coordinated, highly...
Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood-Based Tests for Key Cancer Mutations
NEW YORK, June 22 /PRNewswire/ -- Exosome Diagnostics, Inc. ("ExosomeDX") and DxS Ltd. ("DxS") today announced that they will collaborate on the development of blood-based companion diagnostics for key cancer gene mutations, such as KRAS, BRAF and EGFR. The collaboration will use DxS' industry le...
NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
NEW YORK, June 15 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has signed an exclusive 10-year agreement with Enhance BioMedical Holdings...
New rotors could help develop nanoscale generators
In collaboration with the Chinese Academy of Sciences in Beijing, scientists have investigated the rotation of molecules on a fixed surface to understand how they may help in the development of future rotor-based machinery at nanoscale level.
The research focused on rotating magnetic fields, ...
China Sky One Medical, Inc. Appoints Pricewaterhouse Coopers to Help Develop a SOX 404 Compliance Program
HARBIN, China, May 19 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical,
Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading
fully integrated pharmaceutical company producing over-the-counter drugs in
the People's Republic of China ("PRC"), today announced that it e...
Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
Schering-Plough Assumes Exclusive Worldwide Marketing Rights for Mometasone Furoate/Formoterol Combination for Asthma and COPD
KENILWORTH, N.J., May 19 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced changes to its global collaboration with Novartis for th...
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
Alliance Aims to First Develop
Powerful Tools for Detecting Ovarian Cancer Earlier
FRANKLIN LAKES, N.J. and MALVERN, Pa., May 4 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ) and Fujirebio Diagnostics, Inc., announced today the signing of a worldwide development ...
EClips Energy Technologies, Inc. To Develop New 'Sterile Air' Product Using PATI Technology
Technology eliminates biological and chemical contaminants in the air
ST. PETERSBURG, Fla., May 1 /PRNewswire-FirstCall/ -- EClips Energy Technologies, Inc. , (OTC Bulletin Board: ECET) announced today the initiation of a project to design and manufacture a domestic air sterilizing system ut...
ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
FREDERICK, Md., April 29 /PRNewswire/ -- ImQuest BioSciences and Arisyn Therapeutics jointly announced today that they have entered into a strategic drug development partnership to provide support necessary to develop
Arisyn's portfolio of novel inhibitors for the treatment of infectious disease a...
Researchers develop new way to see single RNA molecules inside living cells
Biomedical engineers have developed a new type of probe that allows them to visualize single ribonucleic acid (RNA) molecules within live cells more easily than existing methods. The tool will help scientists learn more about how RNA operates within living cells.
Techniques scientists currently...
ArunA Biomedical Submits Contract Proposal to Further Develop Environmental Biosensor for National Security
ArunA Biomedical Submits Contract Proposal to Further Develop
Environmental Biosensor for National Security
ATHENS, Ga., March 31 /PRNewswire/ -- ArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has submitted a Department of De...
ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security
ATHENS, Ga., March 31 /PRNewswire/ -- ArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has been awarded a Department of Defense contract to develop
an environmental biosensor utilizing its human stem cell technology.
Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins
TEMPE, Ariz., March 31 /PRNewswire/ -- Intrinsic Bioprobes, Inc. today announced the start of a contract with the National Cancer Institute to develop
effective technologies for accurate measurement of cancer-related proteins and peptides that improve diagnostic capabilities by effectively discern...
Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology
ROCKVILLE, Md. and EXTON, Pa., March 25 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) and Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced that they have entered into a collaboration to discover, develop
and commercialize therapeutic...
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
- Up to $50 Million Potential Milestones plus Double Digit Royalties on Future Sales -
- Company to Host Conference Call at 11:00 a.m. ET Today -
EMERYVILLE, Calif., March 25 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY ), a mid-stage biopharmaceutical comp...
Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
TSX Venture: QPT
EDMONTON, March 18 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer and dermatological conditions, today announced that it has formed a strategi...
Hebrew University scientist develop technique for eliminating reblockage of arteries
Jerusalem, March 9, 2009 An easily implementable technique to avoid reblockage of arteries that have been cleared through angioplasty and stent insertion has been developed by researchers led by Prof. Boris Rubinsky of the Hebrew University of Jerusalem.
Angioplasty is the "gold-standard" tr...
OLIGOMERIX Awarded NIH Grant to Develop Novel Biomarkers for Alzheimer's Disease
NEW YORK, Feb. 25 /PRNewswire/ -- OLIGOMERIX, Inc. today announced the receipt of a Small Business Innovation Research (SBIR) Phase I grant for $323,000 from the National Institute on Aging of the National Institutes of Health (NIH). The focus of the program is to develop
novel biomarker assays fo...
Innovative Biosensors and ProGenTech Partner to Develop a Rapid Diagnostics System
ROCKVILLE, Md. and EMERYVILLE, Calif., Feb. 24 /PRNewswire/ -- Innovative Biosensors, Inc., and ProGenTech Limited, two emerging leaders in life science & diagnostics, today announced an agreement to jointly develop
a rapid, integrated diagnostic system. The system will incorporate Innovative ...
CFSO Calls for Roundtable to Develop National Strategy for Advancing Forensic Sciences in the United States
DENVER, Feb. 17 /PRNewswire-USNewswire/ -- AAFS Convention -- With
tomorrow's release of the Forensics Study by the National Academy of Sciences,
The Consortium of Forensic Science Organizations (CFSO) has announced that:
-- Peter Marone, CFSO chairman, will be available to the media f...
Energy, Biotechnology and Agribusiness Veterans Form SG Biofuels to Develop Jatropha as Low-Cost, Sustainable Oil
SG Biofuels assembles world's largest library of Jatropha genetic material
SAN DIEGO, Feb. 2 /PRNewswire/ -- Following three years of research, a team of energy, biotechnology and agribusiness veterans today announced the formation of SG Biofuels , a San Diego, CA-based plant oil company spe...
IDRI Collaborates with the Brazilian Butantan Institute To Develop Novel Vaccines Against Leishmaniasis
SEATTLE, Jan. 22 /PRNewswire/ -- IDRI (Infectious Disease Research
Institute) announced it has granted the Instituto Butantan, a Brazilian
biomedical research institution, an exclusive license in Latin America and a
non-exclusive license in the rest of the world to use two of IDRI's lead
BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies
LUDWIGSHAFEN, Germany and ST. LOUIS, Jan. 20 /PRNewswire-FirstCall/ --
BASF and Monsanto Company (NYSE: MON ) today announced a new joint-licensing
agreement to accelerate the development of the next-generation of dicamba-
based weed control chemistry products. Both parties will participate ...
Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
LAIYANG, China, Jan. 13 /PRNewswire-Asia-FirstCall/ -- Genesis
Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the
"Company"), a U.S. pharmaceutical company with its principal operations in the
People's Republic of China, today announced that it engaged KPMG Huazhen
Micell Forges Strategic Agreement to Develop Advanced Drug-Eluting Stents and Balloons
Company In-licenses State-of-the-art CE-Marked Cobalt-Chromium Coronary Stent
Forms Alliance to Jointly Develop
Drug Eluting Balloon Products
RALEIGH, N.C., Jan. 12 /PRNewswire/ -- Micell Technologies announced today that that the company entered into a strategic agreement with Maxcor In...
Sigma-Aldrich Enters Into Research Collaboration Program With D-Finitive Cell Technologies, Inc., to Develop Research Tools for Regenerative Medicine
ST. LOUIS, Nov. 25 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL )
announced today it has entered into a research collaboration program with
D-Finitive Cell Technologies, Inc. This collaboration is expected to support
the development and commercial offering of 14 products over a two-yea...
SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
AUSTIN, Texas, Nov. 12 /PRNewswire/ -- SpineSmith Partners, an
innovative bio-medical device company, is collaborating with several senior
design teams in The University of Texas Biomedical Engineering Department
to help educate students on the design, engineering, and commercialization
Azur Pharma and Elan Corporation (NYSE: ELN) Sign Agreement to Develop a Once-Daily Clozapine
DUBLIN, November 10 /PRNewswire/ -- Azur Pharma Limited ("Azur") today
announced that it has entered into an agreement to develop
commercialise once-daily formulations of clozapine using Elan Corporation
plc's ("Elan")(NYSE: ELN ) proprietary drug delivery technologies, including
South Africa's Minister of Minerals and Energy Welcomes Denham Capital Investment in BioTherm Energy to Develop Power Generation Business
Partnership will help alleviate South African power crisis
JOHANNESBURG, South Africa and BOSTON Nov. 9 /PRNewswire/ -- Denham
Capital, a leading energy-focused global private equity firm, announced
today that it will invest equity of up to R1,5 billion (US $150 million, 95
million pounds St...
Trius Awarded $28 Million Contract to Develop Novel Antibiotics
Funding from NIAID of National Institutes of Health
SAN DIEGO, Oct. 22 /PRNewswire/ -- Trius Therapeutics, Inc., today
announced the award of a $28 million contract from the National Institute
of Allergy and Infectious Diseases (NIAID), a component of the National
Institutes of Health, for t...